Meningitis: Difference between revisions
(Add MedicationDose entry (dexamethasone) with SMW annotations) |
(Major update: CSF interpretation table, empiric antibiotics by age, dexamethasone timing (before/with abx), CT before LP indications, jolt accentuation, meningococcal prophylaxis, references with PMIDs) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Inflammation of the meninges (membranes surrounding the brain and spinal cord) | |||
*'''Bacterial meningitis is a medical emergency''' — mortality 15-25% even with treatment; up to 50% untreated<ref>van de Beek D, et al. Community-acquired bacterial meningitis. ''Nat Rev Dis Primers''. 2016;2:16074. PMID 27808261</ref> | |||
*Bacterial meningitis | *'''Time to antibiotics is the most critical intervention''' — every hour of delay increases mortality | ||
* | |||
=== | ===Common Organisms by Age=== | ||
* | *'''Neonates (<1 month)''': Group B Streptococcus (GBS), ''E. coli'', ''Listeria monocytogenes'' | ||
* | *'''Infants/Children (1 month - 18 years)''': ''Neisseria meningitidis'', ''Streptococcus pneumoniae'', ''Haemophilus influenzae'' type b (less common post-vaccination) | ||
*'''Adults (18-50)''': '''S. pneumoniae''' (most common), '''N. meningitidis''' | |||
*'''Adults >50, immunocompromised, alcoholics''': S. pneumoniae, '''Listeria''', gram-negative bacilli | |||
*'''Post-neurosurgical/VP shunt''': ''Staphylococcus'' species, gram-negative bacilli | |||
=== | ===Viral Meningitis=== | ||
*Most common cause overall; '''enterovirus''' in majority | |||
*Generally self-limited; much better prognosis than bacterial | |||
* | |||
* | |||
==Clinical Features== | ==Clinical Features== | ||
*'''Classic triad''' (headache, fever, neck stiffness): present in '''only ~44% of bacterial meningitis''' | |||
* | *At least '''2 of 4''' (headache, fever, neck stiffness, AMS) present in '''95%'''<ref>van de Beek D, et al. Clinical features and prognostic factors in adults with bacterial meningitis. ''N Engl J Med''. 2004;351(18):1849-1859. PMID 15509818</ref> | ||
* | *'''Headache''' (87%), '''fever''' (77%), '''neck stiffness''' (83%) | ||
* | *'''Altered mental status''' (ranging from confusion to coma) | ||
* | *'''Photophobia''' | ||
*'''Kernig sign''': pain with knee extension when hip is flexed (sensitivity ~5%) | |||
*'''Brudzinski sign''': involuntary hip flexion with passive neck flexion (sensitivity ~5%) | |||
*'''Jolt accentuation''': worsening headache with horizontal head rotation (better sensitivity than Kernig/Brudzinski) | |||
*'''Petechial/purpuric rash''': highly suggestive of '''N. meningitidis''' (meningococcemia) | |||
*Neonates: irritability, poor feeding, bulging fontanelle, hypothermia or fever | |||
*Elderly: may present with '''only confusion''' without classic features | |||
==Differential Diagnosis== | |||
*[[Subarachnoid hemorrhage]] | |||
*[[ | *[[Encephalitis]] | ||
* | *Brain abscess | ||
*[[ | *[[Subdural hemorrhage]] / epidural abscess | ||
*[[ | *[[Stroke]] | ||
* | *Viral meningitis | ||
* | *Carcinomatous meningitis | ||
* | *Drug-induced meningitis (NSAIDs, IVIG, TMP-SMX) | ||
{{Altered mental status and fever DDX}} | |||
{{ | |||
==Evaluation== | ==Evaluation== | ||
=== | ===DO NOT DELAY ANTIBIOTICS FOR LP=== | ||
*If '''LP will be delayed''' (CT needed, patient unstable): '''give antibiotics FIRST, then CT, then LP''' | |||
*Blood cultures should be drawn before antibiotics when possible (do not delay abx for cultures) | |||
===Lumbar Puncture=== | |||
*'''CT BEFORE LP''' only if: | |||
**Immunocompromised, history of CNS disease | |||
**New-onset [[seizures]] | |||
**[[Papilledema]] | |||
**Focal neurologic deficits | |||
**Altered level of consciousness (GCS <10-12) | |||
*'''CSF findings''': | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| | ! Parameter !! '''Bacterial''' !! '''Viral''' !! '''TB/Fungal''' | ||
|- | |||
|| | | Opening pressure || '''Elevated (>20 cm H2O)''' || Normal/mild ↑ || Elevated | ||
|- | |- | ||
| | | WBC || '''1000-5000+ (PMN predominant)''' || 10-500 (lymphocytes) || 50-500 (lymphocytes) | ||
|| | |||
|- | |- | ||
| | | Glucose || '''<40 mg/dL (or CSF:serum <0.4)''' || Normal || Low | ||
|| | |||
|- | |- | ||
| | | Protein || '''Elevated (>250 mg/dL)''' || Mild elevation || Elevated | ||
|- | |||
| Gram stain || Positive in 60-90% || Negative || Negative (AFB rarely +) | |||
|| | |||
|} | |} | ||
=== | ===Labs=== | ||
*Blood cultures (before antibiotics if possible) | |||
*CBC, BMP, lactate, coagulation studies | |||
*'''Procalcitonin''' (may help distinguish bacterial from viral; level >0.5 ng/mL supports bacterial) | |||
*'''CSF studies''': cell count with differential, protein, glucose, Gram stain, culture | |||
*Consider: CSF lactate, HSV PCR, cryptococcal antigen, meningitis/encephalitis PCR panel | |||
=== | ==Management== | ||
===Empiric Antibiotics (Give IMMEDIATELY if Suspected)=== | |||
*'''Adults <50 years''': | |||
**'''Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h''' | |||
*'''Adults >50 years, immunocompromised, or alcoholics''': | |||
**'''Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h + ampicillin 2g IV q4h''' (Listeria coverage) | |||
*'''Neonates''': | |||
**'''Ampicillin + gentamicin''' (or ampicillin + cefotaxime) | |||
*'''Post-neurosurgical/VP shunt''': | |||
**'''Vancomycin + cefepime (or meropenem)''' | |||
=== | ===Dexamethasone=== | ||
* | *'''Dexamethasone 0.15 mg/kg IV q6h x 4 days''' | ||
* | *'''Give with or just before FIRST dose of antibiotics'''<ref>de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. ''N Engl J Med''. 2002;347(20):1549-1556. PMID 12432041</ref> | ||
*'''Greatest benefit in pneumococcal meningitis''' (reduced mortality and hearing loss) | |||
*If given >1 hour after antibiotics, benefit is reduced — '''do not withhold antibiotics for dexamethasone''' | |||
== | ===Viral Meningitis=== | ||
* | *Supportive care (analgesia, antiemetics, IV fluids) | ||
*If '''HSV encephalitis''' suspected: '''acyclovir 10 mg/kg IV q8h''' (do NOT wait for confirmation) | |||
===Meningococcal Prophylaxis=== | |||
*Close contacts of confirmed N. meningitidis require prophylaxis: | |||
**'''Rifampin 600 mg PO q12h x 2 days''' OR | |||
== | **'''Ciprofloxacin 500 mg PO x 1 dose''' (preferred for adults) OR | ||
* | **'''Ceftriaxone 250 mg IM x 1 dose''' (preferred for pregnant women) | ||
*Notify public health | |||
* | |||
* | |||
* | |||
* | |||
** | |||
* | |||
==Disposition== | ==Disposition== | ||
*'''Admit all patients with suspected bacterial meningitis''' to ICU or monitored bed | |||
*Admit with | *Viral meningitis: may discharge if well-appearing, tolerating PO, reliable follow-up | ||
*'''Repeat LP''' not routinely needed if clinically improving | |||
* | |||
==See Also== | ==See Also== | ||
*[[Encephalitis]] | |||
*[[Subarachnoid hemorrhage]] | |||
*[[Lumbar puncture]] | |||
*[[Meningitis (peds)]] | *[[Meningitis (peds)]] | ||
*[[ | *[[Brain abscess]] | ||
*[[Sepsis]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
*Tunkel AR, et al. Practice guidelines for the management of bacterial meningitis. ''Clin Infect Dis''. 2004;39(9):1267-1284. PMID 15494903 | |||
*Brouwer MC, et al. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. ''Clin Microbiol Rev''. 2010;23(3):467-492. PMID 20610819 | |||
*McGill F, et al. Acute bacterial meningitis in adults. ''Lancet''. 2016;388(10063):3036-3047. PMID 27265346 | |||
[[Category: | [[Category:Infectious Disease]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Critical Care]] | |||
Revision as of 19:52, 21 March 2026
Background
- Inflammation of the meninges (membranes surrounding the brain and spinal cord)
- Bacterial meningitis is a medical emergency — mortality 15-25% even with treatment; up to 50% untreated[1]
- Time to antibiotics is the most critical intervention — every hour of delay increases mortality
Common Organisms by Age
- Neonates (<1 month): Group B Streptococcus (GBS), E. coli, Listeria monocytogenes
- Infants/Children (1 month - 18 years): Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b (less common post-vaccination)
- Adults (18-50): S. pneumoniae (most common), N. meningitidis
- Adults >50, immunocompromised, alcoholics: S. pneumoniae, Listeria, gram-negative bacilli
- Post-neurosurgical/VP shunt: Staphylococcus species, gram-negative bacilli
Viral Meningitis
- Most common cause overall; enterovirus in majority
- Generally self-limited; much better prognosis than bacterial
Clinical Features
- Classic triad (headache, fever, neck stiffness): present in only ~44% of bacterial meningitis
- At least 2 of 4 (headache, fever, neck stiffness, AMS) present in 95%[2]
- Headache (87%), fever (77%), neck stiffness (83%)
- Altered mental status (ranging from confusion to coma)
- Photophobia
- Kernig sign: pain with knee extension when hip is flexed (sensitivity ~5%)
- Brudzinski sign: involuntary hip flexion with passive neck flexion (sensitivity ~5%)
- Jolt accentuation: worsening headache with horizontal head rotation (better sensitivity than Kernig/Brudzinski)
- Petechial/purpuric rash: highly suggestive of N. meningitidis (meningococcemia)
- Neonates: irritability, poor feeding, bulging fontanelle, hypothermia or fever
- Elderly: may present with only confusion without classic features
Differential Diagnosis
- Subarachnoid hemorrhage
- Encephalitis
- Brain abscess
- Subdural hemorrhage / epidural abscess
- Stroke
- Viral meningitis
- Carcinomatous meningitis
- Drug-induced meningitis (NSAIDs, IVIG, TMP-SMX)
Template:Altered mental status and fever DDX
Evaluation
DO NOT DELAY ANTIBIOTICS FOR LP
- If LP will be delayed (CT needed, patient unstable): give antibiotics FIRST, then CT, then LP
- Blood cultures should be drawn before antibiotics when possible (do not delay abx for cultures)
Lumbar Puncture
- CT BEFORE LP only if:
- Immunocompromised, history of CNS disease
- New-onset seizures
- Papilledema
- Focal neurologic deficits
- Altered level of consciousness (GCS <10-12)
- CSF findings:
| Parameter | Bacterial | Viral | TB/Fungal |
|---|---|---|---|
| Opening pressure | Elevated (>20 cm H2O) | Normal/mild ↑ | Elevated |
| WBC | 1000-5000+ (PMN predominant) | 10-500 (lymphocytes) | 50-500 (lymphocytes) |
| Glucose | <40 mg/dL (or CSF:serum <0.4) | Normal | Low |
| Protein | Elevated (>250 mg/dL) | Mild elevation | Elevated |
| Gram stain | Positive in 60-90% | Negative | Negative (AFB rarely +) |
Labs
- Blood cultures (before antibiotics if possible)
- CBC, BMP, lactate, coagulation studies
- Procalcitonin (may help distinguish bacterial from viral; level >0.5 ng/mL supports bacterial)
- CSF studies: cell count with differential, protein, glucose, Gram stain, culture
- Consider: CSF lactate, HSV PCR, cryptococcal antigen, meningitis/encephalitis PCR panel
Management
Empiric Antibiotics (Give IMMEDIATELY if Suspected)
- Adults <50 years:
- Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h
- Adults >50 years, immunocompromised, or alcoholics:
- Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h + ampicillin 2g IV q4h (Listeria coverage)
- Neonates:
- Ampicillin + gentamicin (or ampicillin + cefotaxime)
- Post-neurosurgical/VP shunt:
- Vancomycin + cefepime (or meropenem)
Dexamethasone
- Dexamethasone 0.15 mg/kg IV q6h x 4 days
- Give with or just before FIRST dose of antibiotics[3]
- Greatest benefit in pneumococcal meningitis (reduced mortality and hearing loss)
- If given >1 hour after antibiotics, benefit is reduced — do not withhold antibiotics for dexamethasone
Viral Meningitis
- Supportive care (analgesia, antiemetics, IV fluids)
- If HSV encephalitis suspected: acyclovir 10 mg/kg IV q8h (do NOT wait for confirmation)
Meningococcal Prophylaxis
- Close contacts of confirmed N. meningitidis require prophylaxis:
- Rifampin 600 mg PO q12h x 2 days OR
- Ciprofloxacin 500 mg PO x 1 dose (preferred for adults) OR
- Ceftriaxone 250 mg IM x 1 dose (preferred for pregnant women)
- Notify public health
Disposition
- Admit all patients with suspected bacterial meningitis to ICU or monitored bed
- Viral meningitis: may discharge if well-appearing, tolerating PO, reliable follow-up
- Repeat LP not routinely needed if clinically improving
See Also
References
- ↑ van de Beek D, et al. Community-acquired bacterial meningitis. Nat Rev Dis Primers. 2016;2:16074. PMID 27808261
- ↑ van de Beek D, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-1859. PMID 15509818
- ↑ de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549-1556. PMID 12432041
- Tunkel AR, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. PMID 15494903
- Brouwer MC, et al. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467-492. PMID 20610819
- McGill F, et al. Acute bacterial meningitis in adults. Lancet. 2016;388(10063):3036-3047. PMID 27265346
